Pakistan, May 16 -- The Drug Regulatory Authority of Pakistan (DRAP) has issued long-awaited notification of fixation of maximum retail price (MRP) of 35 advanced life-saving drugs, it was learnt on Friday.

The medicines include treatments for cancer, heart disease, and typhoid.

"The notification has enabled pharmaceutical manufacturers to begin commercial production and/or import the notified medicines. Such processes may take one to two months to make the medicines available in markets." Pakistan Pharmaceutical Manufacturers Association (PPMA) senior vice chairman Kamran Nasir told the media.

"The maximum retail price shall not be applicable on drugs whose registrations under sub-rule (4) of rule 29 of the Drugs (Licensing, Registrat...